(S)-7-(2-Methoxy-3,5-dimethylpyridin-4-yl)-1-(tetrahydrofuran-3-yl)-1H-pyrazolo[4,3-c]quinolin-4(5H)-one

Catalog No. :
ACCTBO773
CAS No. :
1429509-82-9
Molecular Formula :
C22H22N4O3
Molecular Weight :
390.44

IUPAC Name:(S)-7-(2-methoxy-3,5-dimethylpyridin-4-yl)-1-(tetrahydrofuran-3-yl)-1,5-dihydro-4H-pyrazolo[4,3-c]quinolin-4-one

(S)-7-(2-Methoxy-3,5-dimethylpyridin-4-yl)-1-(tetrahydrofuran-3-yl)-1H-pyrazolo[4,3-c]quinolin-4(5H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg95%$333.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-7-(2-Methoxy-3,5-dimethylpyridin-4-yl)-1-(tetrahydrofuran-3-yl)-1H-pyrazolo[4,3-c]quinolin-4(5H)-one
IUPAC Name(S)-7-(2-methoxy-3,5-dimethylpyridin-4-yl)-1-(tetrahydrofuran-3-yl)-1,5-dihydro-4H-pyrazolo[4,3-c]quinolin-4-one
Molecular FormulaC22H22N4O3
Molecular Weight390.44
SMILESO=C1NC2=C(C=CC(C3=C(C)C(OC)=NC=C3C)=C2)C4=C1C=NN4[C@@H]5COCC5
InChI KeyCKJDCNZBABIEBZ-HNNXBMFYSA-N
SynonymIrsenontrine | 4H-PYRAZOLO(4,3-C)QUINOLIN-4-ONE, 1,5-DIHYDRO-7-(2-METHOXY-3,5-DIMETHYL-4- PYRIDINYL)-1-((3S)-TETRAHYDRO-3-FURANYL)- | IRSENONTRINE [INN] | UNII-54QB00NNRB | EX-A6062 | E2027 | CKJDCNZBABIEBZ-HNNXBMFYSA-N | 7-(2-Methoxy-3,5-dimethylpyridin-
CAS No.1429509-82-9
PubChem CID136253996

Synthetic Route by SureRoute

1. ACCTBO773 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCTBO773 route product structure diagram
    ACCTBO7731429509-82-9
Inquiry

2. ACCTBO773 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXWUI937 route compound structure diagram
    ACXWUI9371429510-64-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCTBO773 route product structure diagram
    ACCTBO7731429509-82-9
Inquiry

Comments (0)